Optimal planning of phase II/III programs for clinical trials with multiple endpoints (Q5978237)

From MaRDI portal
Revision as of 02:22, 24 March 2024 by Daniel (talk | contribs) (‎Created claim: Wikidata QID (P12): Q53397556, #quickstatements; #temporary_batch_1711234560214)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Optimal planning of phase II/III programs for clinical trials with multiple endpoints
scientific article

    Statements

    DOI
    10.1002/pst.1861
    0 references
    volume
    17
    0 references
    issue
    5
    0 references
    page(s)
    437-457
    0 references
    publication date
    26 April 2018
    0 references
    author
    Marietta Kirchner
    0 references
    Eva Dölger
    0 references
    Heiko Götte
    0 references
    Meinhard Kieser
    0 references
    Wikidata QID
    Q53397556
    0 references
     
    Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Item:Q5978237&oldid=33197763"
    Powered by MediaWiki